AANEM News Express

AANEM News Express

Science News: Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID

5/31/2022
 
Submitted by: Niranjan Singh, MD
Edited by: Vishwajit Hegde, MD


Oaklander AL, Mills AJ, Kelley M, et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):e1146. Published 2022 Mar 1. doi:10.1212/NXI.0000000000001146
 
Summary: In this retrospective analysis, authors analyzed cross-sectional and longitudinal data from patients with World Health Organization (WHO)-defined long COVID without prior neuropathy history or risks who were referred for evaluation of neuropathy.
 
The study found that small fiber neuropathy after mild COVID-19 was most common beginning within a month of disease onset. The study is suggestive of infection-triggered immune dysregulation as a common mechanism.
 
Among 17 patients analyzed by the study group, 16 had mild COVID-19. Among the patients with mild COVID-19, 10/16 of lower leg skin biopsies pathologically confirmed small fiber neuropathy. The initial SFN scores were abnormal - reduced to 40.7%. Distal muscle weakness, absent ankle reflex, abnormal distal pinprick, and vibrations were noted. Treatment was comprised of corticosteroids and/or IV immunoglobulin (IVIG). Response to the treatment was variable.
 
Comment: Reports of peripheral neuropathy, mononeuritis multiplex, brachial plexitis, cranial neuropathy, and orthostatic intolerance have been reported in patients with COVID-19. Patients with mild or asymptomatic COVID-19 or patients who recovered from more severe infections continue to present with unexplained fatigue/exertional intolerance, dysautonomia symptoms, and sensory concerns. Those patients may need workup for small fiber neuropathy including skin biopsy and treatment with immunomodulation.
 
Though the study has a small number of patients, small fiber neuropathy appears to be the most prevalent in this group with long COVID-19. Some patients treated with steroid and most patients treated with sustained IVIG perceived improvement. A spontaneous recovery was also documented. This supports the hypothesis that some long COVID-19 symptoms reflect underlying small fiber neuropathy.
 
The current study neither confirms causality nor the clinical significance of magnitude of any association. More research is required.
 
Articles of Similar Interest:
Oaklander AL, Nolano M. Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review. JAMA Neurol. 2019;76(10):1240-1251
 
Zirpoli G, Downs S, Farhad K, Oaklander AL. Initial validation of the Mass General neuropathy exam tool (MAGNET) for diagnosing small-fiber polyneuropathy. Ann Neurol. 2018. Proccedings of the 2018 meeting of the American Neurological Association.


View Related News Stories:

  EducationScience NewsNSEB


Recent AANEM News

Remembering George Kraft, MD, MS

The American Clinical Neurophysiology Society to Hold Another Townhall Meeting of Clinical Neurophysiology, Epilepsy, and Neuromuscular Fellowship Program Directors

Science News: Amyotrophic Lateral Sclerosis and Noninvasive Positive Pressure Ventilatory Support: "Nasal Noninvasive Ventilation" or "Noninvasive Ventilatory Support"?

CMS Finalizes Updates to Physician Fee Schedule

Advocacy in Action: State Liaison Leads the Way for Patient Advocacy in Washington and Beyond





Advertisement

ABEM

Advertisement

Donate

Advertisement